Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib

Indonesia Berita Berita

Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Reuters
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 97%

Japan's biggest drugmaker, Takeda Pharmaceutical Co Ltd, said long-term dat...

- Japan’s biggest drugmaker, Takeda Pharmaceutical Co Ltd, said long-term data show better outcomes for its Alunbrig drug in certain lung cancer patients compared to an existing treatment.

Oncology is a pillar for Takeda as it refocuses on core businesses following last year’s $59 billion takeover of Britain’s Shire. The announcement followed a week of investor conferences at home and in the United States intended to show that its drug pipeline is robust enough to fuel continued growth.

“This is a profoundly exciting study,” said Rachael Brake, Takeda’s global program leader in oncology. “The benefit in the overall study population, as well as in patients with baseline brain metastises, is associated with an improved quality of life relative to crizotinib.” Alunbrig is a tyrosine kinase inhibitor designed to target and inhibit the ALK fusion protein in non-small cell lung cancer. It received accelerated approval from the U.S. Food and Drug Administration in April 2017 for certain cancer patients who had progressed on or were intolerant to crizotinib, a similar class of drug.Non-small cell lung cancer is the most common form among the estimated 1.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Reuters /  🏆 2. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Cancer immunotherapy drug 'prolongs life'Cancer immunotherapy drug 'prolongs life'Pembrolizumab held advanced head and neck cancers in a group of patients at bay for around two years.
Baca lebih lajut »

‘The Late Show With Stephen Colbert’ Talks About A Drug Deal That Was Breaking Bad‘The Late Show With Stephen Colbert’ Talks About A Drug Deal That Was Breaking BadSomething was being cooked in the Ukraine matter, according to impeachment inquiry testimony from Dr. Fiona Hill, a former official at the National Security Council specializing in Soviet, Russian …
Baca lebih lajut »

https://people.comhttps://people.comGet the latest news about celebrities, royals, music, TV, and real people. Find exclusive content, including photos and videos, on PEOPLE.com.
Baca lebih lajut »

Ex-'American Idol' contestant Antonella Barba blames her drug arrest on the showEx-'American Idol' contestant Antonella Barba blames her drug arrest on the showAntonella Barba's time on 'American Idol' is “where it all went wrong,' her mother wrote as part of a request for a reduced sentence.
Baca lebih lajut »

Sorry Angels, the Victoria's Secret Fashion Show Is Now CancelledSorry Angels, the Victoria's Secret Fashion Show Is Now CancelledAfter much speculation, the 2019 Victoria's Secret Fashion Show has officially been canned. Model Shanina Shaik previously teased the demise of the iconic event.
Baca lebih lajut »



Render Time: 2025-04-01 22:47:19